[1]
M. Remenčiūtė, G. Varžaitytė, and G. Žemgulytė, “The Effect of Calcitonin Gene-Related Peptide Monoclonal Antibodies on Quality of Life among Migraine Patients: Pilot Study at the Hospital of Lithuanian University of Health Sciences Kaunas Clinics”, AML, vol. 31, no. 1, pp. 41–51, May 2024, doi: 10.15388/Amed.2024.31.1.12.